Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation and resistant to imatinib

被引：0
|
作者：
Tiribelli, M. [1 ]
Sperotto, A. [1 ]
Candoni, A. [1 ]
Simeone, E. [1 ]
Buttignol, S. [1 ]
Fanin, R. [1 ]
机构：
[1] Div Hematol & BMT, Udine, Italy
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S433 / S434
页数：2
相关论文
共 50 条
  • [1] NILOTINIB AND DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PHALL) RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND RESISTANT TO IMATINIB
    Tiribelli, M.
    Sperotto, A.
    Candoni, A.
    Simeone, E.
    Buttignol, S.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 430 - 430
  • [2] Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib
    Tiribelli, Mario
    Sperotto, Alessandra
    Candoni, Anna
    Simeone, Erica
    Buttignol, Silvia
    Fanin, Renato
    LEUKEMIA RESEARCH, 2009, 33 (01) : 174 - 177
  • [3] Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia
    Fielding, A. K.
    Goldstone, A. H.
    BONE MARROW TRANSPLANTATION, 2008, 41 (05) : 447 - 453
  • [4] Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia
    A K Fielding
    A H Goldstone
    Bone Marrow Transplantation, 2008, 41 : 447 - 453
  • [5] Imatinib mesylate (gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation
    Sugimoto, K
    Mikoshiba, M
    Ohashi, K
    Akiyama, H
    Sakamaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (04) : 440 - 442
  • [6] Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
    Keiji Sugimoto
    Michiaki Mikoshiba
    Kazuteru Ohashi
    Hideki Akiyama
    Hisashi Sakamaki
    International Journal of Hematology, 2002, 75 : 440 - 442
  • [7] Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion
    Tachibana, Takayoshi
    Numata, Ayumi
    Tanaka, Masatsugu
    Motohashi, Kenji
    Fujisawa, Shin
    Fujita, Hiroyuki
    Sakai, Rika
    Tomita, Naoto
    Maruta, Atsuo
    Ishigatsubo, Yoshiaki
    Kanamori, Heiwa
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1376 - 1379
  • [8] Restoration of full donor chimerism with nilotinib in imatinib resistant CML relapsing after allogeneic stem cell transplantation
    Langabee, S. E.
    Molloy, K. M.
    McCarron, S. L.
    Haslam, K.
    O'Connor, L. M.
    Kelly, J.
    Conneally, E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 48 - 48
  • [9] EXCELLENT OUTCOME AFTER T CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION WITH PRE-EMPTIVE DONOR LYMPHOCYTE INFUSION FOR PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST REMISSION
    Eefting, M.
    Halkes, C.
    Kersting, S.
    van Pelt, C.
    Marijt, E.
    von dem Borne, P.
    Veelken, J.
    Falkenburg, J.
    HAEMATOLOGICA, 2012, 97 : 486 - 486
  • [10] Haematological remission induced by donor leukocytes infusion in a case of Philadelphia positive acute lymphoblastic leukaemia relapsing after allogeneic bone marrow transplantation
    Saw, MH
    Teh, A
    Wong, HC
    Bosco, J
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 65 (02) : 173 - 178
12345